Note 12 - Restatement (Tables)

9 Months Ended

Sep. 30, 2022

Notes Tables

Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]

	September 30, 2022
Consolidated Balance Sheet Information:	As Previously Reported			As Restated
Accounts receivable	$	7,804,369		$	3,384,936
Inventory, net		3,603,852			5,954,375
Inventory deposits		4,812,439			4,855,049
Total current assets		21,589,819			19,563,519
Total assets		73,749,477			71,723,177
Accrued liabilities		1,154,026			767,026
Notes payable, net		27,444			414,444
Accumulated deficit		(11,535,272	)		(13,561,572	)
Total stockholders’ equity		72,388,228			70,361,928
Total liabilities and stockholders’ equity		73,749,477			71,723,177

	Three Months Ended September 30, 2022					Nine Months Ended September 30, 2022
Consolidated Statement of Operations Information:	As Previously Reported		As Restated			As Previously Reported			As Restated
Sales	$	3,882,670	$	1,029,280		$	7,078,870		$	2,625,090
Cost of sales		2,046,491		677,855			3,998,533			1,599,290
Gross profit		1,836,179		351,425			3,080,337			1,025,800
General and administrative expenses		1,619,210		1,584,973			6,142,194			6,113,957
Income (loss) from operations		97,782		(1,352,735	)		(3,438,774	)		(5,465,074	)
Income (loss) before income taxes		126,749		(1,323,768	)		(3,410,912	)		(5,437,212	)
Net income (loss)	$	126,749	$	(1,323,768	)	$	(3,410,912	)	$	(5,437,212	)
Net income (loss) per share – basic and diluted	$	0.01	$	(0.09	)	$	(0.23	)	$	(0.36	)